Control over Drug Acquisition, Preparation, and Injection: Implications for HIV and HCV Risk among Young Female Injection Drug Users
ISRN Addiction · 2013
DOI: 10.1155/2013/289012 ↗Kurz gefasst
Fachartikel in der Zeitschrift ISRN Addiction, 2013. Verfasst von Karla D Wagner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Global Public Health, Department of Medicine, University of California, San Diego; 9500 Gilman Drive MC 0849; La Jolla CA 92093; kdwagner…. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.
Abstract (Originalsprache)
Young female injection drug users (IDUs) are at risk for HIV/HCV, and initiating the use of a new drug may confer additional and unexpected risks. While gender differences in the social context of injection drug use have been identified, it is unknown whether those differences persist during the initiation of a new drug. This mixed-methods study examined the accounts of 30 young female IDUs in Los Angeles, CA, USA from 2004 to 2006, who described the social context of initiating injection drug use and initiating ketamine injection. The analysis aimed to understand how the social context of young women’s injection events contributes to HIV/HCV risk. Women’s initiation into ketamine injection occurred approximately 2 years after their first injection of any drug. Over that time, women experienced changes in some aspects of the social context of drug injection, including the size and composition of the using group. A significant proportion of women described injection events characterized by a lack of control over the acquisition, preparation, and injection of drugs, as well as reliance on friends and sexual partners. Findings suggest that lack of control over drug acquisition, preparation, and injection may elevate women’s risk; these phenomena should be considered as a behavioral risk factor when designing interventions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Global Public Health, Department of Medicine, University of California, San Diego; 9500 Gilman Drive MC 0849; La Jolla CA 92093; kdwagner@ucsd.edu.
- Division of Adolescent Medicine, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California; 4650 Sunset Blvd., MS 2, Los Angeles, CA 90027; jejackson@chla.usc.edu.
- Department of Nursing, Psychiatry, New York University Langone Medical Center, 550 First Avenue, New York, NY 10016 dodihathazi@gmail.com.
- School of Criminal Justice and Criminalistics, California State University Los Angeles; 5151 State University Drive, Los Angeles, CA 90032; bsander2@calstatela.edu.
- Department of Community Health and Prevention, Drexel University School of Public Health; 1505 Race Street, Bellet Building, Philadelphia, PA 19102-1192; sel59@drexel.edu.
Förderung
- NIDA NIH HHS
- National Institute on Drug Abuse
Zitieren
APA
Wagner, K. D., Bloom, J. J., Hathazi, S. D., Sanders, B., & Lankenau, S. E. (2013). Control over Drug Acquisition, Preparation, and Injection: Implications for HIV and HCV Risk among Young Female Injection Drug Users. ISRN Addiction. https://doi.org/10.1155/2013/289012
Vancouver
Wagner KD, Bloom JJ, Hathazi SD, Sanders B, Lankenau SE. Control over Drug Acquisition, Preparation, and Injection: Implications for HIV and HCV Risk among Young Female Injection Drug Users. ISRN Addiction. 2013. doi:10.1155/2013/289012
BibTeX
@article{Wagner2013,
author = {Wagner, Karla D and Bloom, Jennifer Jackson and Hathazi, Susan Dodi and Sanders, Bill and Lankenau, Stephen E},
title = {Control over Drug Acquisition, Preparation, and Injection: Implications for HIV and HCV Risk among Young Female Injection Drug Users},
journal = {ISRN Addiction},
year = {2013},
doi = {10.1155/2013/289012}
}
EUVIMED